Effect of Naftpidil to generic QOL

Effect of Naftpidil to generic QOL - Effect of Naftpidil to generic QOL

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000000982

Enrollment

100

Registered

2008-02-01

Start date

2007-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

LUTS/BPH

Interventions

100 cases

Quastionnaires for urinary symptoms(IPSS) and generic QOL(SF-8) are anwered before, after 4 and 8 weeks taking Naftpidil.

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Those who have LUTS/BPH and are considered for medical treatment

Exclusion criteria

Exclusion criteria: contraindication for Naftpidil

Design outcomes

Primary

Measure	Time frame
Whether Naftpidil affects generic QOL; which sub-domain is mostly affected?	—

Countries

Japan

Contacts

Public ContactAkira Komiya

Faculty of Medicine, University of Toyama Department of Urology

akirakomiya@mac.com

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026